T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting

Area of Science:

• Neuro-oncology
• Nanomedicine
• Gene Therapy

Background:

• Glioma is a deadly brain tumor with poor prognosis.
• Gene therapy, particularly RNA interference (RNAi), shows therapeutic potential.
• The blood-brain barrier (BBB) and blood tumor barrier (BTB) impede effective gene delivery to brain tumors.

Purpose of the Study:

• To develop a dual-targeting gene delivery system to overcome BBB and BTB for glioma treatment.
• To enhance the efficacy of RNA interference (RNAi) in brain tumors.
• To create a safe and efficient nanomedicine platform for brain tumor therapy.

Main Methods:

• Synthesized a gene delivery system targeting the transferrin (Tf) receptor.
• Utilized U87 cells expressing luciferase to simulate glioma.
• Conducted in vitro and in vivo RNAi experiments to evaluate gene silencing activity.

Main Results:

• The dual-targeting system successfully targeted the transferrin receptor on BBB and glioma cells.
• Gene silencing activity was 2.17-fold higher with the targeting ligand modification.
• The system demonstrated high efficiency, low toxicity, stability, and high transfection efficiency.

Conclusions:

• The developed dual-targeting gene delivery system effectively overcomes BBB and BTB for glioma.
• This nanomedicine approach significantly enhances RNAi efficacy in brain tumors.
• The system presents a promising strategy for RNAi therapeutics and nanomedicine in treating brain tumors.